✦ LIBER ✦

Coronary Heart Disease and Stroke with Aromatase Inhibitor, Tamoxifen, and Menopausal Hormone Therapy Use

✍ Scribed by Rowan T. Chlebowski; Garnet L. Anderson; Michelle Geller; Nananda Col

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hormone therapy and coronary heart disea

✍ Gerrie-Cor M. Gast; Victor J.M. Pop; Göran N. Samsioe; Diederick E. Grobbee; Pet 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 224 KB

Cost-utility of adjuvant hormone therapi

✍ C. Skedgel; D. Rayson; R. Dewar; T. Younis 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 694 KB

Changes in coronary heart disease risk f

✍ J. Dallongeville; N. Marecaux; D. Isorez; G. Zylberberg; J.C. Fruchart; P. Amouy 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Menopausal Hormone Therapy and Coronary

✍ Jacques E. Rossouw 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 328 KB

Aromatase inhibitors versus tamoxifen as

✍ Mette L. Josefsson; Samuel J. Leinster 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 953 KB

Hormone replacement therapy and cardiova

✍ G. D. O. Lowe 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB